Abiopharma

Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026

Ealixir Reports Full Year 2025 Results

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

eToros AI investing companion Tori gets real-time X intelligence, powered by Grok 4.2

Valvoline Inc. Named One of America’s Most Trustworthy Companies by Newsweek

Client Growth & Engagement Drive Record Schwab 1Q Results

ZipRecruiter Finds Grad Job Market Improving Despite Fears That AI Is Eliminating Jobs

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026

Babcock & Wilcox Enterprises, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BW

PHARMING GROUP NV (PHAR) Files Form 6-K

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001839882-26-020292 <b>Size:</b> 543 KB

Annual General Meeting :

Extraordinary/ Special General Meeting:

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change of Interest of Director - Ow Yong Thian Soo